Showing results (101-110 of 1,736) with videos related to

Sort By:
Pageof 174
Harm Reduction Journal|April 1, 2021
Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York CityJacob Ziff, Trang Vu, Danielle Dvir, et al.
Harm Reduction Journal|April 13, 2023
Women who use drugs: engagement in practices of harm reduction careTamar Austin, Jennifer Lavalley, Sylvia Parusel, et al.
Harm Reduction Journal|May 3, 2023
COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York CityDon C Des Jarlais, Chenziheng Allen Weng, Jonathan Feelemyer, et al.
Harm Reduction Journal|May 23, 2023
Not all screens are created equal: examination of surface features and other physical properties of commonly used screen materials for smoking drugsBradley J Diak, Miroslav Miskovic, Nadia Zurba, et al.
Harm Reduction Journal|April 25, 2023
Gendered perspectives on women's anabolic-androgenic steroid (AAS) usage practicesTim Piatkowski, Jonathan Robertson, Severine Lamon, et al.
Harm Reduction Journal|April 18, 2015
Prevalence of HIV and other infections and correlates of needle and syringe sharing among people who inject drugs in Podgorica, Montenegro: a respondent-driven sampling surveyDragan Lausevic, Senad Begic, Boban Mugosa, et al.
Harm Reduction Journal|April 18, 2015
A qualitative study trialling the acceptability of new hepatitis C prevention messages for people who inject drugs: symbiotic messages, pleasure and conditional interpretationsCarla Treloar, Jamee Newland, Louise Maher
Harm Reduction Journal|July 24, 2020
Opioid agonist therapy uptake among people who inject drugs: the findings of two consecutive bio-behavioral surveillance surveys in IranMehran Nakhaeizadeh, Zahra Abdolahinia, Hamid Sharifi, et al.
Harm Reduction Journal|July 25, 2020
A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health dataKristen A Morin, Joseph K Eibl, Graham Gauthier, et al.
Harm Reduction Journal|April 14, 2021
'I perceive it to be less harmful, I have no idea if it is or not:' a qualitative exploration of the harm perceptions of IQOS among adult usersKatherine A East, Charlotte N E Tompkins, Ann McNeill, et al.
Pageof 174